These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 8562725

  • 21. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T.
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [Abstract] [Full Text] [Related]

  • 22. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K, Ishiguro T.
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F, Risse A.
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A, Bharadwaj R, Grover S.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ, Sethi KD.
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neuroleptic malignant syndrome in Mexico.
    Montoya A, Ocampo M, Torres-Ruiz A.
    Can J Clin Pharmacol; 2003 Nov; 10(3):111-3. PubMed ID: 14506509
    [Abstract] [Full Text] [Related]

  • 36. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Nov; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H, Buchkremer G.
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.